<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Interpreting Sameness of Gene Therapy Products Under the Orphan Drug Regulations; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Interpreting Sameness of Gene Therapy Products Under the Orphan Drug Regulations; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2020-01-30 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft document entitled "Interpreting Sameness of Gene Therapy Products Under the Orphan Drug Regulations." The draft guidance document provides FDA's current thinking on the criteria to determine sameness of human gene therapy products for the purpose of orphan drug designation and orphan drug exclusivity. The draft guidance is intended to assist stakeholders, including industry and academic sponsors who seek o...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-01705</p>
    <p><strong>Publication Date:</strong> 2020-01-30</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/01/30/2020-01705/interpreting-sameness-of-gene-therapy-products-under-the-orphan-drug-regulations-draft-guidance-for">https://www.federalregister.gov/documents/2020/01/30/2020-01705/interpreting-sameness-of-gene-therapy-products-under-the-orphan-drug-regulations-draft-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-01705</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
